362 Phenotypic plasticity in epithelial progenitors and mesenchymal carcinoma is regulated by Axl signaling
Engelsen, A, Wnup-Lipinska, K, Tiron, C, Pelissier, F, Jokela, T, Haaland, G, Gausdal, G, Sandal, T, Frink, R, Liang, X, Hinz, S, Ahmed, L, Hellesøy, M, Mickelm, D, Minna, J, LaBarge, M, Brekken, R, Lorens, J
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
PB1723 DEVELOPING NOVEL COMBINED CSF1R/FLT3‐TARGETED THERAPY IN ACUTE MYELOID LEUKAEMIA
Sletta, K., Gjertsen, B.T., Sabir, M., Hellesøy, M., Surleaux, D., Haslene‐Hox, H., Popa, M.L.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
PS999 SINGLE CELL SIGNALING PHARMACODYNAMICS IN A PHASE 1B CLINICAL TRIAL OF THE AXL INHIBITOR BEMCENTINIB IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Hellesøy, M., Fagerholt, O.H. E., Tislevoll, B.S., Gullaksen, S.E., Forthun, R.B., Hovland, R., Reikvam, H., Kittang, A.O., Cortes, J., Micklem, D., Holt, R.J., Loges, S., Gjertsen, B.T.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
S835 MASS CYTOMETRY REVEAL EARLY SIGNALING RESPONSES TO INDUCTION THERAPY IN IMMUNOPHENOTYPICALLY DEFINED LEUKEMIC CELL SUBSETS THAT PREDICT SURVIVAL IN AML
Tislevoll, B.S., Fagerholt, O.H.E., Hellesøy, M., Gullaksen, S.‐E., Duran, P.A., Piechaczyk, L., Tadele, D., Skavland, J., Gavasso, S., Hovland, R., Enserink, J., Fløisand, Y., Blaser, N., Gjertsen, B.T.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
PF259 THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL‐INHIBITOR AND LOW‐DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY
Loges, S., Heuser, M., Chromik, J., Vigil, C.E., Paschka, P., Re, F., Di Renzo, N., Lemoli, R., Mattei, D., Ben Batalla, I., Hellesøy, M., Micklem, D., Holt, R.J., Schoelermann, J., Lorens, K., Lorens, J.B., Shoaib, M., Aly, H., Brown, A., Fiedler, W.M., Cortes, J.E., Gjertsen, B.T.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
Malani, Disha, Kumar, Ashwini, Brück, Oscar, Kontro, Mika, Yadav, Bhagwan, Hellesøy, Monica, Kuusanmäki, Heikki, Dufva, Olli, Kankainen, Matti, Eldfors, Samuli, Potdar, Swapnil, Saarela, Jani, Turunen, Laura, Parsons, Alun, Västrik, Imre, Kivinen, Katja, Saarela, Janna, Räty, Riikka, Lehto, Minna, Wolf, Maija, Gjertsen, Bjorn Tore, Mustjoki, Satu, Aittokallio, Tero, Wennerberg, Krister, Heckman, Caroline A, Kallioniemi, Olli, Porkka, Kimmo
Published in Cancer discovery (01.02.2022)
Published in Cancer discovery (01.02.2022)
Get full text
Journal Article
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types
Majumder, Muntasir M, Leppä, Aino-Maija, Hellesøy, Monica, Dowling, Paul, Malyutina, Alina, Kopperud, Reidun, Bazou, Despina, Andersson, Emma, Parsons, Alun, Tang, Jing, Kallioniemi, Olli, Mustjoki, Satu, O'Gorman, Peter, Wennerberg, Krister, Porkka, Kimmo, Gjertsen, Bjørn T, Heckman, Caroline A
Published in Haematologica (Roma) (01.06.2020)
Published in Haematologica (Roma) (01.06.2020)
Get full text
Journal Article